Chronic food-restriction decreases brain serotonin transporter in the rat by Paternoster, Richard
City University of New York (CUNY) 
CUNY Academic Works 
Student Theses Baruch College 
1-1-1997 




How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/bb_etds/48 
Discover additional works at: https://academicworks.cuny.edu 
This work is made publicly available by the City University of New York (CUNY). 
Contact: AcademicWorks@cuny.edu 
Chronic Food-Restriction Decreases Brain 




Submitted to the Committee on Undergraduate Honors at Baruch College of the City 
University of New York in partial fulfillment of the requirements for the degree of 










Figures and Table 1
LIST OF ABBREVIATIONS
ACTH- Adrenocorticotropic hormone
Cl, C2, C3, C4- Control Group (Ad Libitum) Rats
CRH- Corticosterone-releasing hormone
fmols- femtomoles ( 1 x 10-15 moles)






mM- millimolar (1 x 10-6 Molar)
mRNA- Messenger RNA
nm- nanometer (1 x 10-9 meters)
nM- nanomolar (1 x 10-9 Molar)
3H-paroxetine- Tritiated (radioa ctively labeled) paroxetine
PCPA- p-chlorophenylalanine
pmols- picomoles (1 x 10-12 moles)
PVN- Paraventricular nucleus of the hypothalamus
RPM- Revolutions per minute
TrOH- Tryptophan hydroxylase enzyme
ul- microliter (1 x 10-6 liters)
uM- micromolar (1 x 10-6 Molar)
5-HT- 5-hydroxytryptamine (Serotonin)
5-HTP- 5-hydroxytryptophan (Serotonin metabolite)
SUMMARY
Serotonin (5-HT), a chemical found in various brain regions including the hippocampus, 
brainstem, cortex, and striarum, acts as a neurotransmitter, i.e., it transmits messages from 
one nerve cell to another. Certain nerve cells release 5-HT into the synapse, the space 
between two or more communicating nerve cells. Once in the synapse, 5-HT influences 
the behavior of nearby nerve cells by acting on specific 5-HT receptors on their surfaces. 
The effects of 5-HT are terminated by the removal of 5-HT from the synapse by the same 
nerve cells that originally released it. The reuptake of 5-HT by these cells is carried out 
by specific 5-HT transporter sites in their cell membranes.
Disturbances in neurotransmission mediated by 5-HT may have a role in depression, 
anxiety and other psychological disorders. Serotonin's most studied effect is that on 
appetite. Experimentally elevated brain 5-HT levels are correlated with an activation of 
satiety and decreased food ingestion in rats. Food-restriction is a widely used protocol for 
obtaining decreased 5-HT levels in rats. Decreased brain 5-HT levels can also be 
obtained by treating animals with p-chlorophenylalanine (PCPA), an inhibitor of 5-HT 
synthesis.
The present study examines the relationship between chronic food-restriction and 5-HT 
transporter site concentration in rats. Chemical depletion of 5-HT by treatment with 
PCPA has been shown to decrease the concentration of 5-HT transporter site messenger 
RNA (mRNA), a molecule required for the synthesis of new 5-HT transporter sites. A 
decrease in 5-HT transporter site mRNA concentration would. be expected to lead to a 
decrease in 5-HT transporter sites.
Because no one has yet studied the relationship between food-restriction and 5-HT 
transporter site density in rats, we decided to determine if chronic food-restriction causes 
a decrease in the 5-HT transporter site density. Knowledge of this decrease in rats due to 
food-restriction may be used as an animal model to better study bulimia, obesity, and 
depression, which are treated effectively with 5-HT reuptake inhibitors such as Prozac, 
fluoxetine, and sertraline.
Experimentation was carried out utilizing a total of 24 male Sprague-Dawley rats. These 
24 rats were separated into 3 experiments of 8 rats each. The three experiments were 
carried out at different periods. In each group, 4 rats were kept on a food-restricted diet of 
10g of food per day and the remaining 4 rats were fed ad libitum (intake is approximately 
20-30g of food per day) for 14 days. Therefore, 12 rats in total were food-restricted and 
12 were fed ad libitum. At the end of the 14 days, all of the subjects were sacrificed. The 
hippocampus, striaturn, brainstem, and cortex regions of the brain were removed, frozen, 
and stored. The density of 5-HT transporter sites (the sites at which released 5-HT is 
taken back into the cell) was estimated by measuring paroxetine-binding by membranes 
from cells in these brain regions. Paroxetine is known to bind to 5-HT transporter sites.
In this study, food-restriction produced a significant decrease in 5-HT transporter sites in 
the brainstem and hippocampus in two of the three experimental groups. The level of 5-
HT transporter sites was significantly decreased in the striatum in only one of the 
experimental groups. Although a sizable decrease (34%) was seen in the striatum of a 
second group, the finding was not significant due to a large standard deviation. Food-
restriction produced no decrease in 5-HT transporter sites in the cortex for any 
experimental group.
The results from one of the experimental groups (group 2) differed from the others. The 
levels of 5-HT transporter sites were higher in the group 2 rats (in both control and food-
restricted animals) than in the other groups, and the decrease in 5-HT transporter sites 
seen in food-restricted rats in groups I and 3 was not found in the group 2 rats. The group 
2 rats were from a different commercial supplier. Perhaps the group 2 rats were slightly 
different genetically or perhaps they were fed or handled differently prior to their arrival 
at the laboratory. These hypotheses remain to be tested.
In summary, we obtained positive results from the 5-HT transporter site density assays, 
showing that food-restriction not only decreases the concentration of brain 5-HT, but also 
decreases the 5-HT transporter site density. Since there is a decrease in the concentration 
of 5-HT in the synapse during periods of chronic food-restriction, the cell may 
compensate for this decrease by keeping as much of this reduced amount of 5-HT as 
possible in the synapse. This may be achieved by reducing the amount of 5-HT 
transporter sites, through which 5-HT is taken back into the cell. This information could 
be very helpful in future endeavors to treat appetite disorders such as bulimia and obesity 
and psychological disorders such as depression in which 5-HT has a putative role.
ABSTRACT
Chemical depletion of brain serotonin (5-HT) by the synthesis inhibitor, p-
chlorophenylalanine, decreases 5-HT transporter mRNA levels, displaying a positive 
relationship between the levels of brain 5-HT and 5-HT transporters. Since food-
restriction is known to cause a decrease in serotonin levels in certain brain regions, a 
concomitant decrease in 5-HT transporter site density due to food restriction might be 
expected. In this study, selected brain regions of rats on food-restricted and ad libitum 
diets were dissected and the density of 5-HT transporter sites in these regions was 
measured using paroxetine-binding assays. It was found that food-restricted rats had 
decreased levels of 5-HT transporter sites in the hippocampus, brainstem, and striatum. 
Such information could be useful in an animal model in the study of bulimia, obesity, and 
depression, disorders which are effectively treated with 5-HT reuptake inhibitors.
INTRODUCTION
Serotonin, 5-hydroxytryptamine (5-HT), is a neurotransmitter whose synthesis begins 
with the binding of the amino acid L-tryptophan to the enzyme tryptophan hydroxylase 
(TrOH)- the rate limiting enzyme in the synthesis of 5-HT. The addition of oxygen and 
the cofactor H4 Biopterine allows for the hydroxylation of L-tryptophan thereby 
producing 5-hydroxytryptophan (5-HTP). A cofactor is a substance, usually a metal, 
which is frequently required by an enzyme to catalyze a reaction. Hydroxylation is the 
addition of a hydroxyl group (-OH) to a molecule. In this case, L-tryptophan is 
hydroxylated to produce 5-HTP. An L-amino acid decarboxylase enzyme then removes a 
carboxyl group (-COOH) from 5-HTP to produce serotonin (2) (Figure 1).
The rate-limiting step in the synthesis of 5-HT is the activity of TrOH (2) and is probably 
directly correlated with the available amount of L-tryptophan which comes from the diet 
(37). The Km value of L-tryptophan, which represents the concentration ofsubstrate which 
allows the enzyme to function at half of its maximum rate, for TrOH is approximately 50 
uM (0.05 mM) (12).
5-HT axons are located in many regions of the brain. The most densely 5-HT-innervated 
regions in rats are the frontal cortex, amygdala, basal forebrain, and most of the 
brainstem. The posterior cerebral cortex, parts of the diencephalon, cerebellum and white 
matter are less densely innervated (36). In the forebrain, 5-HT-containing fibers emanate 
from two nuclei in the brainstem. Fibers from the dorsal raphe nuclei contain axon 
terminals with fine varicosities (approx. 1-2 um). Fibers from the median raphe nuclei 
contain axon terminals with larger varicosities (approx. 3-4 um) (25,28). Reductions in 5-
HT levels in the forebrain of both rodents and non-human primates have been shown to 
occur after administration of several amphetamines, namely 3,4-
methylenedioxyamphetamine (33), 3,4-methylenedioxymethamphetamine (12), and N-
ethyl-3,4-methylenedioxyamphetamine (34). These amphetamines are used recreationally 
by humans and denervate the fine-fibered axons (36). Although 5-HT axons are found 
throughout the brain, the largest reservoirs of 5-HT are located in the blood and in the 
gastrointestinal mucosa (20).
5-HT axons also display a degree of regeneration. Ten days subsequent to the injection of 
a neurotoxin that causes the destruction of 5-HT containing axons (2), into the spinal cord 
of animals whose axons had been damaged, it was found that new axons had appeared in 
the medulla oblongata (2). After three months, new fibers were also seen in the spinal 
cord. Normal connections and projections were noted along with abnormal ones (2).
5-HT is thought to have a modulatory role on temperature, pain, sex behavior, the 
regulation of sleep, locomotor activity, avoidance learning, water consumption, self-
stimulation, and aggression (2). 5-HT may also play a role in psychiatric disorders. 
Impulsivity, depression, anxiety and obsessive-compulsive disorders may be caused, in 
part, by disturbances in the neurotransmission mediated by 5-HT (10,40). 5-HT is also 
thought to have a role in the onset of migraines (18), cerebral vasospasms, and in cerebral 
blood flow (9).
One of the most studied roles of 5-HT deals with appetite. Elevated 5-HT levels have 
been shown to cause the activation of satiety in food-restriction studies (6,7,13). These 
studies have utilized 5-HT reuptake inhibitors, e.g., fenfluramine and fluoxetine, and 5-
HT receptor antagonists, e.g., metergoline and methysergide. Reuptake inhibitors prevent 
5-HT from binding to its transporter and result in a greater amount of extracellular 5-HT 
because of a decreased amount of 5-HT allowed back into the cell. Antagonists are drugs 
which block the receptors of a neurotransmitter and therefore inhibit the neurotransmitter 
from binding to the receptor. Fenfluramine, which is most effective in the paraventricular 
nucleus (PVN) of the hypothalamus, has an anorectic effect on rats (41), and fluoxetine 
causes a decrease in the size of the meals consumed by food-restricted rats (11,25,27). 
This decrease in the size of meals consumed is blocked by the administration of 
metergoline, a 5-HT2A receptor antagonist (21). Methysergide, a second 5-HT2 receptor 
antagonist, causes a stimulation of feeding in rats which are well-sated (25,39). 
Furthermore, food intake inhibition has also been observed after administration of 5-HT1B
receptor agonists (22-24,27,38). This information displays that appetite is reduced by 
elevated levels of free 5-HT.
5-HT receptors are classified according to three definitive criteria: operational (the drug-
related characteristics of the receptor), structural, and transductional (receptor-effector 
coupling events). These transductions occur via a second messenger system whereby the 
binding of a chemical to a receptor leads to a change in the concentration of the second 
messenger, e.g., adenyl cyclase. This change in concentration usually leads to an 
alteration in the activity of an enzyme and therefore results in the eventual physiological 
effect of the chemical. 5-HT2 receptors are structurally different from 5-HT1 receptors, 
they are affected by different drugs, and transduce their effects through phosphoinositide 
metabolism as compared to 5-HT1 receptors which transduce their effects by being 
negatively linked to adenyl cyclase (17).
The effects of 5-HT on appetite are not only seen through the use of antagonists, agonists, 
and reuptake inhibitors, but also directly with 5-HT. Administration of 5-HT into the 
PVN was shown to reduce carbohydrate intake by rodents (26). Carbohydrate intake was
also attenuated when 5-HT was administered into the medial hypothalamus of rodents 
given a high-protein and high-carbohydrate diet (39). Therefore, increased extracellular 
5-HT causes reduced carbohydrate intake.
This effect of 5-HT may be explained through an influence of 5-HT on the lateral 
hypothalamus (LH). Neurons in the LH initiate feeding behavior and 5-HT has been 
shown to have an inhibitory effect on these neurons (42). Rodents do not have the ability 
to vomit. Instead, when an unfavorable substance has been ingested, a conditioned taste 
aversion ensues where the rodent will no longer ingest that substance. A conditioned taste 
aversion to saccharin solution can be instilled in rodents. When a saccharin solution, to 
which a conditioned taste aversion had been instilled, was orally infused into rodents, 
elevated levels of 5-HT were observed in the LH. The same elevated levels were also 
noted in rodents receiving injections of lithium chloride (LiCl), which is illness inducing. 
(42).
Chemical depletion of brain 5-HT due to administration of the 5-HT synthesis inhibitor 
p-chlorophenylalanine (PCPA) has been shown to be correlated with a decrease in 5-HT 
transporter mRNA levels (32). 5-HT levels are elevated during and after a meal and are 
decreased during periods of food-restriction (29). Since a positive correlation has been 
observed between the concentration of brain 5-HT and mRNA levels of 5-HT 
transporters, 5-HT transporter site density may also be decreased during periods of food-
restriction. In this study, we desired to determine if, in fact, chronic food-restriction does 
cause a decrease in 5-HT transporter site density.
MATERIALS AND METHODS
Food-Restriction
Twenty-four male Sprague-Dawley rats weighing from 300-350g were separated into 
three experimental groups of eight rats each. These eight rats were individually caged and 
used during one two-week period of food-restriction. Each group of rats was subjected to 
the following protocol at different periods. They arrived at the NYU animal facility on 
Day I and were given three days to become accustomed to the surroundings prior to food-
restriction. On Day 4 food carriers were removed from the cages of two of the food-
restricted subjects. Food carriers with unlimited food were retained in the cages of 
control, ad libitum, rats. These two subjects were designated FR1 and FR2, and two 
control rats were designated Cl and C2. On Day 5, the food carriers were removed from 
the cages of the remaining two food-restricted subjects. These subjects were designated 
FR3 and FR4 and the final two rats were designated C3 and C4. Also on Day 5, subjects 
FR1 and FR2 were given only 10g of food pellets between the hours of 2PM and 5PM 
and were fed in this manner for the duration of the experiment. Subjects FR3 and FR4 
were started on their 10g of food pellets per day diet on Day 6. Controls were fed ad 
libitum and their typical daily intake was in the range of 20 to 30 grams.
This staggered feeding schedule was utilized in order to sacrifice only four subjects per 
day after the 14 days of food-restriction. On Day 18, subjects C1, C2, FR1, and FR2 were 
sacrificed approximately at 2PM. On this day, no food was given to subjects FR1 and 
FR2. Subjects FR3 and FR4 were sacrificed on Day 19.
The method used to sacrifice the subjects was to first anesthetize them with carbon 
dioxide and then decapitate them with a guillotine. Several regions of the brain-
hippocampus, cortex, brainstem, and striatum- were then dissected and placed on dry ice. 
These regions were stored at -70 C until further use. The hippocampus, cortex, brainstem, 
and striatum were utilized because they are regions which contain the greatest amount of 
serotonergic innervation.
Homogenization of Brain Regions
The dissected sections of the subject's brains - brainstem, cortex, hippocampus and 
striatum - were removed from the -70 C freezer and individually weighed. Each section 
was then placed into a separate centrifuge tube containing 7 ml of paroxetine buffer 
(composed of 38.5 mM Tris-HCl, 11.5mM Tris-Base, 120mM NaCl, and 5mM KCl), pH 
7.4, and homogenized for 10 second's utilizing a Polytron homogenizer. Following 
homogenization, the samples were centrifuged for 20 minutes at 17,000 RPM to isolate 
plasma membrane fractions. Subsequently, the supernatant was removed and the pellet 
re-suspended in a 1:80 dilution of paroxetine buffer. The weight of each brain region was 
multiplied by 80 and that value became the amount of paroxetine buffer added to each 
tube. Samples were once again homogenized, placed into separate 50 ml plastic conical 
tubes, and then frozen at -70 C until use. Prior to freezing, however, I ml of each 
homogenate was pipetted into 1 ml microfuge tubes and frozen separately for use in a 
Lowry protein assay.
Lowry Protein Assay
The homogenized tissue samples stored at -70 C were brought to room temperature. 160 
ul of the tissue was pipetted into separate glass test tubes followed by 840 ul of double-
distilled H20. Then, 1 ml of ABC solution (0.15% Sodium deoxycholate; 72% 
trichloroacetic acid; copper tartrate/carbonate solution; 20% Folin-Ciocalteu reagent) was 
added to each tube, and the tubes were vortexed. After 15 minutes of incubation at room 
temperature, 3 ml of Folin's Reagent (2N Phenol Reagent Solution), in a 1:10 dilution, 
was added to each tube, the tubes were vortexed, and incubation at room temperature was 
continued for 1 hour. 1 ml of the mixture was then removed from the tubes and placed 
into cuvette for spectrophotometrical analysis at a wavelength of 570 nm.
Standards were prepared utilizing concentrations of bovine serum albumin ranging from 
100 ug/ml to 1 mg/ml. The results were interpreted and converted to mg/ml of protein 
utilizing the Radlig EDBA Version 3.0 program by McPherson. These results were later 
used to calculate the fmol of bound paroxetine per mg of protein in the sample.
3H-Paroxetine Binding Assay
The frozen, homogenized tissue samples were brought to room temperature and 160 ul of 
each was added to eight plastic test tubes. Four of these tubes contained only 40 ul of 
paroxetine (0.25 nM) without any fluoxetine to test for total binding, and the remaining 
four contained 40 ul of fluoxetine (1 uM) to obtain the amount of non-specific binding. 
Fluoxetine blankets the binding sites and therefore displaces the 3H-paroxetine. This 
allowed for the detection of non-specific binding, which was subtracted from the total 
binding to obtain the specific binding value of 3H-paroxetine. These tubes were then 
vortexed and incubated for 15 minutes at room temperature. Subsequently, 200 ul of 3H-
paroxetine buffer was added to each tube. The samples were then incubated for 120 
minutes at room temperature. Following this final incubation, the samples were filtered 
over 0.1% polyethyleneimine (PEI) coated filters utilizing a Brandell cell harvester. PEI 
prevents any free ligand from binding to the filter. Each glass fiber filter was then placed 
into a glass test tube which was filled with 5 ml of Ecoscint A scintillation fluid. The 
tubes were then placed into a scintillation counter to count the amount of 3H-paroxetine 
bound to the rat brain membrane homogenates.
The values obtained for the fluoxetine binding of each tissue sample, i.e., Subject C1 
Cortex, Subject C1 Brainstem, etc., were subtracted from those obtained from the 
paroxetine binding of the same sample. This new value was the amount (pmol) of 
specific binding of 3H-paroxetine to serotonergic transporter sites. This specific binding 
value was divided by the specific activity of the 3H-paroxetine, (21 Curies/mmole) 
24,000 counts per minute/pmol, to obtain the amount of paroxetine bound to the terminal 
preparations (membrane homogenates). Finally, this amount of bound paroxetine was 
divided by the concentration of protein of each sample obtained from the Lowry assay to 
result in the fmols of paroxetine bound to terminal preparations/mg of protein. Statistical 
analysis was conducted utilizing a two-tailed Student's t-test. All data points were 
recorded as Mean + SEM of four animals per group.
RESULTS
Weight Changes Caused by Food Restriction
On the day of sacrifice, food-restricted rats weighed approximately 85% of their initial 
starting weight, whereas ad libitum rats weighed approximately 120% of their initial 
starting weight. Mean body weights and percentages of starting weights are listed in 
Table 1 and plotted in Figure 3.
Quantification of 5-HT Transporter Sites
Hippocampus
In two of the three paroxetine-binding assays (experimental groups 1 and 3), there were 
significant reductions in the density of 5-HT transporter sites in the hippocampus of food-
restricted rats (Figure 4). In the first experimental group, there was a decrease of 39% in 
the density of 5-HT transporter sites in the hippocampus in the food-restricted subjects as 
compared to the control subjects. Specifically, the control subjects had an average of 156 
fmol/mg of specific 3H-paroxetine binding compared to 96 fmol/mg of specific 3H-
paroxetine binding in food-restricted subjects. The p values, which denote the level of 
significance chosen as our standard, were required to be below 0.05 in all of the assays. 
The p value for this experimental group was 0.003. The third experimental group also 
displayed a decrease in the 5-HT transporter sites in food-restricted subjects. The 
difference was 21% between food-restricted and control subjects, and specifically there 
was 262 fmol/mg average specific 3H-paroxetine binding in the control subjects 
compared to 207 fmol/mg in the food-restricted subjects. The p value for the third 
experimental group was 0.01.
The second experimental group did not display any siginificant decrease in 5-HT 
transporter sites. The p value here was 0.54.
Brainstem
As in the hippocampus, significant reductions in 5-HT transporter site density was also 
seen in the breinstem in experimental groups 1 and 3 (Figure 5). The reduction from 
control to food-restricted subjects was 19% in the first experimental group. The values 
were 187 fmol/mg of specific 3H-paroxetine binding for the controls compared to 151 
fmol/mg for the food-restricted subjects. The p value obtained was 0.01. This reduction 
was approximately 20% from control to food-restricted subjects in the third experimental 
group, and the values were 179 fmol/mg of specific 3H-paroxetine binding forthe controls 
compared to 143 fmol/mg for the food-restricted subjects. The p value was 0.001.
Also as for the hippocampus, the second experimental group showed no significant 
decrease in 5-HT transporter site decrease. The p value for the second experimental group 
was 0.26.
Cortex
The cortex displayed no significant reduction in any of the three experimental groups as 
can be seen in Figure 6. The p values for the cortex of all three experimental groups are 
0.41, 0.81, and 0.185.
Striarum
A significant reduction in 5-HT transporter sites in the striatum was shown in only one of 
the three experimental groups (Figure 7). In experimental group 3, there was a reduction 
of 27.6% in the 5-HT transporter site density from control subjects to food-restricted 
subjects. The p value for this experimental group was 0.01.
Reduction from control subjects to food-restricted subjects was 34% in the first 
experimental group, but the p value for this group was 0.239, due to a high value for the 
standard deviation. Therefore, there was no significant difference in 5-HT transporter site 
density in this group.
As for the other three brain regions, the second experimental group displayed no 
significant reduction in 5-HT transporter site density. The p value was 0.29.
DISCUSSION
In the present study, food-restriction appears to lower 5-HT transporter site density in 
some brain regions. In two of the three experimental groups, food-restriction was shown 
to cause a significant decrease in 5-HT transporter sites in the hippocampus and 
brainstem, and in the striatum in one of the three experimental groups. A large percent 
reduction (39%) in striatal 5-HT transporter site density was seen in a second of the three 
experimental groups, however a large value for the standard deviation (120.9) denoted 
that a wide range of 3H-paroxetine binding values of the control subjects existed, and 
therefore the results were not significant. The results in the second experimental group 
differed markedly from the other two groups. No differences in the density of 5-HT 
transporter sites between ad libitum and food-restricted rats were observed in any brain 
region in the second group of rats.
The only known variable in the second experimental group which was not seen in the 
other two groups was that the rats were obtained from a different supplier. A different 
manner in which they were bred by the supplier, e.g., diet, or a genetic variation due to 
the particular breeding of the rats may have led to the difference in the binding of 
paroxetine to the 5-HT transporter. This hypothesis is not proven, but it would be 
interesting to observe if the same high value of 5-HT transporter site density was again
observed under the identical circumstances. If, in fact, this was the case, it would also be 
interesting and beneficial to see if a difference in the breeding of the rats does take place, 
and if the binding of paroxetine is effected by this factor.
Food-restriction, as presently reported, does result in a decrease in the amount of 5-HT in 
certain brain regions. Less 5-HT is produced by the neurons and therefore, extracellularly 
there is probably less 5-HT. A reason for the decreased level of transporters may be that 
in order to compensate for this reduced level extracellularly, fewer transporters may exist 
to ensure that a reduced amount of 5-HT is taken back into the neurons. 
Immunocytochemical analysis may be helpful to discover the amount of tryptophan 
hydroxylase present in certain brain regions and possibly provide evidence showing 
whether or not food-restriction may have a harmful effect in the synthesis of 5-HT.
The evidence obtained in this study that 5-HT transporter site density in rats is reduced in 
certain brain regions due to chronic food-restriction may contribute to our understanding 
of bulimia and other eating disorders. Bulimia is clinically treated with 5-HT reuptake 
inhibitors such as fluoxetine which binds to the transporter sites on the nerve terminal and 
prevents 5-HT from re-entering the cell. There seems to be, then, a significant correlation 
between 5-HT transporter sites and the effective treatment of bulimia. This current data 
may be used as an animal model in the study of bulimia.
Results of this study suggest further lines of investigation. There is various evidence 
which points to the existence of a strong correlation between the serotonin system and the 
glucocorticoid system. Glucocorticoids are steroids which promote gluconeogenesis (29). 
They are produced and secreted via the hypothalamic-pituitary-adrenal (HPA) axis 
(Figure 8). This axis is initiated by the release of corticosterone-releasing hormone 
(CRH) from the hypothalamus to induce the basophilic cells of the anterior pituitary to 
produce, as well as release, adrenocorticotropic hormone (ACTH). Several 
neurotransmitters, one of which is serotonin, indirectly stimulate the release of CRH at 
this point of the cycle via 5-HT1A and 5-HT2A/2C receptors (29). Glucocorticoids affect the 
serotonin system by stimulating 5-HT synthesis and stress-induced tryptophan 
hydroxylase activity (3,4,5). Further correlation is observed through the fact that 
glucocorticoids are also affected by food-restriction. Plasma corticosterone (the major 
glucocorticoid in rats) levels have been shown to be elevated preceding the scheduled 
daily meal in food-restricted rats (1). Since abnormalities in the HPA axis have been 
shown to be correlated to depression (35,45) and one of the major aberrant behavioral 
effects of disturbances in the neurotransmission of 5-HT is depression (10,40), 
experimentation regarding the correlation between the effects of food-restriction on both 
systems could prove useful.
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Figures and Table 1
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Figure 1. Schematic Representation of the Synthesis of 5-Hydroxytryptamine 
(Serotonin). The synthesis of serotonin is initiated by the hydroxylation of the amino 
acid L-tryptophan catalyzed by the enzyme tryptophan hydroxylase and H4 Biopterin, the 
cofactor. 5-Hydroxtryptophan (5-HTP) is then decarboxylated by L-amino acid 
decarboxylase enzyme to produce 5-HT (Serotonin) (2).
go to larger image
FIGURE 2. Reuptake of Serotonin Via Serotonin (5-HT) Transporter Sites. 
Serotonin, normally contained in nerve terminals, must be released into the synapse (the 
space between two neurons) in order to affect other neurons and transduce its effects on 
appetite, sleep, locomotor activity, and other physiological behaviors. Once the effect has 
taken place, the extracellular serotonin is taken back into the nerve terminal via serotonin 
transporter sites. Such sites can be blocked by serotonin reuptake inhibitors, such as 
paroxetine and Prozac, which compete with serotonin for these transporter sites.
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Figure 3. Weight of Food-Restricted vs. Ad Libitum Rats. The weights in grams (g) of 
both the food-restricted and ad libitum (control) rats were recorded daily during the 14 
day food-restriction period. The rats were tested in three groups of 8 rats each, and each 
group is plotted separately in the graph. Mean starting and ending weights for each group 
are shown in Table 1.
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Figure 4. Effect of Food-Restriction on Hippocampa/ Serotonin Transporter Site 
Density. Male Sprague-Dawley rats were maintained on either a food-restricted or an ad 
libitum (control) diet for 14 days and then sacrificed. Displayed are the results of the 
three 3H-paroxetine binding assays, a measure of 5-HT transporter sites, for the 
hippocampus food-restricted and control rats in each of the three experimental groups. In 
the first and third experimental groups, Hipp 1 and Hipp 3, a significant decrease (p 
<0.05) of the serotonin transporter site density caused by food-restriction was detected. A 
significant decrease was not seen in the second experimental group, Hipp 2.
go to larger image
Figure 5. Effect of Food-Restriction on Brainstem Serotonin Transporter Site 
Density. Male Sprague-Dawley rats were maintained on either a food-restricted or an ad 
libitum (control) diet for 14 days and then sacrificed. Displayed are the results of 3H-
paroxetine binding assays, a measure of the 5-HT transporter site density, for the 
brainstem from food-restricted and control rats in each of the three experimental groups. 
In the first and third experimental groups, Brainstem 1 and Brainstem 3, a significant 
decrease (p <0.05) of the serotonin transporter site density caused by food-restriction was 
detected. A significant decrease was not seen in the second experimental groups.
go to larger image
Figure 6. Effect of Food-Restriction on Cortica/ Serotonin Transporter Site Density. 
Male Sprague-Dawley rats were maintained on either a food-restricted or an ad libitum 
(control) diet for 14 days and then sacrificed. Results from food-restricted subjects were 
compared to ad libitum subjects. Food-restriction did not result in a significant decrease 
(p <0.05) in serotonin transporter sites in any of the three experiments. This figure 
displays the amount of 3H-paroxetine bound to the cortex membrane homogenates in both 
the control and food-restricted subjects. The greater the amount of binding, the greater 
the serotonin transporter site density.
go to larger image
Figure 7. Effect of Food-Restriction on Striatal Serotonin Transporter Site Density. 
Male Sprague-Dawley rats were maintained on either a food-restricted or an ad libitum 
(control) diet for 14 days and then sacrificed.. Results from food-restricted subjects were 
compared to ad libitum subjects. Food-restriction produced a significant decrease (p-
<0.05) in serotonin transporter sites only in the third experimental group, Striaturn 3. No 
significant decrease was detected in the first two experimental groups, Striaturn 1 and 
Striaturn 2. Although the percentage difference between the subjects seemed large, 
especially in group 1, the large standard deviation in the ad libitum values compromised 
the significance.
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Figure 8. Schematic Representation of the Hypothalamic-Pituitary-Adrenal Axis. The 
release of corticosterone is regulated via a negative feedback loop where the greater 
amount of plasma corticosterone present, the less is produced due to an inhibitory 
pathway created by the increased level. Corticosterone-releasing hormone (CRH), which 
is released by the hypothalamus, causes the release of adrenocorticotropic hormone 
(ACTH) from the anterior pituitary. ACTH, in turn, increases the amount of cholesterol 
that is converted to pregnenolone in the adrenal cortex. This then leads to the heightened 
production of corticosterone. Serotonin has a putative neurological role in this system 
through its influence on the hypothalamus and the release of CRH (29).
COMPARISON OF THE STARTING AND ENDING MEAN BODY 
WEIGHTS OF THE SUBJECT GROUPS
FOOD RESTRICTED SUBJECTS
GROUP
Mean Starting Weight 
(g)
Mean Ending Weight 
(g)
% of Starting 
Weight
1 341.5 290.2 85
2 361.7 321.8 89
3 353.9 311.4 88
AD LIBITUM SUBJECTS
GROUP
Mean Starting Weight 
(g)
Mean Ending Weight 
(g)
% of Starting 
Weight
1 333.3 406.3 122
2 368.8 442.8 120
3 349.7 440.6 126
TABLE 1. Weight Change of Subjects During Food-Restriction. The 
weights of each of the 24 rats were recorded prior to and during the period of 
food-restriction, as well as on the day of sacrifice. Averages of beginning 
weights (prior to food-restriction) and ending weights (on the day of sacrifice) of 
food-restricted and control groups wee calculated and the average ending 
weights of each group are displayed as a percentage of the average beginning 
weights of the respective group. 
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